Press Releases
AstraZeneca’s Tagrisso gains full FDA approval for lung cancer
AstraZeneca announced that the US FDA has granted full approval for Tagrisso (osimertinib) 80mg once-daily tablets, for the treatment of patients with metastatic EGFR T790M...
Press Releases
TraceLink Announces NEXUS 17 Keynote Speakers
TraceLink Inc., the world’s largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. ...
Press Releases
Botanix receives export and import approvals for clinical studies...
Botanix Pharmaceuticals is pleased to announce that the US Drug Enforcement Agency (DEA) has approved the export, and the Australian Office of Controlled Substances (ODC)...
Press Releases
Citius Pharma Announces Addition of South America to World...
Citius Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced that it has recently concluded negotiations...
Press Releases
Aptar Pharma Preservative-Free Multidose Dispenser Chosen For The First...
Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is available for patients in the U.S. prescription market for the first time with Allergan’s RESTASIS...
Press Releases
Recipharm partners with Sato to manufacture product for Japanese...
Recipharm, the contract development and manufacturing organisation (CDMO), has entered into a long term agreement with Sato Pharmaceutical Co. for the commercial manufacture and delivery...
Press Releases
X-Chem Announces Strategic Collaboration with Astellas Pharma Across Multiple...
X-Chem, Inc. , a privately held biotechnology company applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, announced the signing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.